Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Scandinavian Journal of Pain

Official Journal of the Scandinavian Association for the Study of Pain

Editor-in-Chief: Breivik, Harald


CiteScore 2018: 0.85

SCImago Journal Rank (SJR) 2018: 0.494
Source Normalized Impact per Paper (SNIP) 2018: 0.427

Online
ISSN
1877-8879
See all formats and pricing
More options …
Volume 19, Issue 3

Issues

Possible inflammatory pain biomarkers in postamputation pain

Nina Stockfleth Buch
  • Corresponding author
  • Department of Anesthesiology and Intensive Care, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, building C319, Aarhus N, Denmark
  • Danish Pain Research Center, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark, Phone: +45 78464317
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Lone Nikolajsen
  • Department of Anesthesiology and Intensive Care, Aarhus University Hospital, Aarhus N, Denmark
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Páll Karlsson
  • Danish Pain Research Center, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
  • Core Center for Molecular Morphology, Section for Stereology and Microscopy Aarhus University Hospital, Aarhus, Denmark
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2019-04-29 | DOI: https://doi.org/10.1515/sjpain-2019-0042

Abstract

Although chronic pain after amputation is frequent, the underlying mechanisms are still not well understood. It is widely accepted that the pathogenesis of postamputation pain is multifactorial, with both peripheral and central mechanisms playing an essential role. However, recent studies suggest that the immune system plays an important role in different neuropathic pain conditions, including postamputation pain. Eleven amputees were included in this clinical study. Information on the type and intensity of spontaneous postamputation pain was obtained and evoked pain responses for brush, cold, and warm allodynia and pinprick hyperalgesia were determined. In addition, skin biopsies were taken from the amputated site and a contralateral control site and analysed for possible markers of pain: IbA1 (macrophages), calcitonin gene-related peptide (CGRP), and substance P (SP). Irrespectively of the type and intensity of postamputation pain, no differences were found in IbA1, CGRP, and SP levels between the amputated site and the control site. Although no differences between the sites were seen in this study, this new method seems promising for our understanding of skin changes in amputees. In future studies, staining for other cytokines and inflammatory mediators in skin biopsies could provide new insight into the mechanisms of postamputation pain.

Keywords: postamputation pain; inflammation; skin biopsies; substans P; calcitonin gene-related peptide; macrophages

References

  • [1]

    Ephraim PL, Wegener ST, MacKenzie EJ, Dillingham TR, Pezzin LE. Phantom pain, residual limb pain, and back pain in amputees: results of a national survey. Arch Phys Med Rehabil 2005;86:1910–9.CrossrefPubMedGoogle Scholar

  • [2]

    Alviar MJ, Hale T, Dungca M. Pharmacologic interventions for treating phantom limb pain. Cochrane Database Syst Rev 2011:CD006380.PubMedGoogle Scholar

  • [3]

    Austin PJ, Moalem-Taylor G. The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines. J Neuroimmunol 2010;229:26–50.CrossrefPubMedWeb of ScienceGoogle Scholar

  • [4]

    Calvo M, Dawes JM, Bennett DL. The role of the immune system in the generation of neuropathic pain. Lancet Neurol 2012;11:629–42.CrossrefWeb of SciencePubMedGoogle Scholar

  • [5]

    Ji RR, Xu ZZ, Gao YJ. Emerging targets in neuroinflammation-driven chronic pain. Nat Rev Drug Discov 2014;13:533–48.Web of SciencePubMedCrossrefGoogle Scholar

  • [6]

    Marchand F, Perretti M, McMahon SB. Role of the immune system in chronic pain. Nat Rev Neurosci 2005;6:521–32.CrossrefPubMedGoogle Scholar

  • [7]

    Chamessian A, Van de Ven T, Buchheit T, Hsia HL, McDuffie M, Gamazon ER, Walsh C, Bruehl S, Buckenmaier C 3rd, Shaw A. Differential expression of systemic inflammatory mediators in amputees with chronic residual limb pain. Pain 2017;158:68–74.PubMedCrossrefWeb of ScienceGoogle Scholar

  • [8]

    Hou Q, Barr T, Gee L, Vickers J, Wymer J, Borsani E, Rodella L, Getsios S, Burdo T, Eisenberg E, Guha U, Lavker R, Kessler J, Chittur S, Fiorino D, Rice F, Albrecht P. Keratinocyte expression of calcitonin gene-related peptide beta: implications for neuropathic and inflammatory pain mechanisms. Pain 2011;152:2036–51.CrossrefPubMedWeb of ScienceGoogle Scholar

  • [9]

    Green DP, Limjunyawong N, Gour N, Pundir P, Dong X. A mast-cell-specific receptor mediates neurogenic inflammation and pain. Neuron 2019;101:412–20 e3.Web of ScienceGoogle Scholar

  • [10]

    Shepherd AJ, Copits BA, Mickle AD, Karlsson P, Kadunganattil S, Haroutounian S, Tadinada SM, de Kloet AD, Valtcheva MV, McIlvried LA, Sheahan TD, Jain S, Ray PR, Usachev YM, Dussor G, Krause EG, Price TJ, Gereau RWt, Mohapatra DP. Angiotensin II triggers peripheral macrophage-to-sensory neuron redox crosstalk to elicit pain. J Neurosci 2018;38:7032–57.CrossrefWeb of SciencePubMedGoogle Scholar

  • [11]

    Lauria G, Hsieh ST, Johansson O, Kennedy WR, Leger JM, Mellgren SI, Nolano M, Merkies IS, Polydefkis M, Smith AG, Sommer C, Valls-Sole J, European Federation of Neurological S, Peripheral Nerve S. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 2010;17:903–12, e44–9.Web of ScienceGoogle Scholar

  • [12]

    Bechakra M, Nieuwenhoff MD, van Rosmalen J, Groeneveld GJ, Scheltens-de Boer M, Sonneveld P, van Doorn PA, de Zeeuw CI, Jongen JL. Clinical, electrophysiological, and cutaneous innervation changes in patients with bortezomib-induced peripheral neuropathy reveal insight into mechanisms of neuropathic pain. Mol Pain 2018;14:1744806918797042.Web of SciencePubMedGoogle Scholar

  • [13]

    Martinez V, Uceyler N, Ben Ammar S, Alvarez JC, Gaudot F, Sommer C, Bouhassira D, Fletcher D. Clinical, histological, and biochemical predictors of postsurgical neuropathic pain. Pain 2015;156:2390–8.CrossrefPubMedWeb of ScienceGoogle Scholar

  • [14]

    Springer JS, Karlsson P, Madsen CS, Johnsen B, Finnerup NB, Jensen TS, Nikolajsen L. Functional and structural assessment of patients with and without persistent pain after thoracotomy. Eur J Pain 2017;21:238–49.CrossrefPubMedWeb of ScienceGoogle Scholar

  • [15]

    Bouhassira D, Attal N, Fermanian J, Alchaar H, Gautron M, Masquelier E, Rostaing S, Lanteri-Minet M, Collin E, Grisart J, Boureau F. Development and validation of the Neuropathic Pain Symptom Inventory. Pain 2004;108:248–57.CrossrefPubMedGoogle Scholar

  • [16]

    Karlsson P, Moller AT, Jensen TS, Nyengaard JR. Epidermal nerve fiber length density estimation using global spatial sampling in healthy subjects and neuropathy patients. J Neuropathol Exp Neurol 2013;72:186–93.Web of ScienceCrossrefPubMedGoogle Scholar

  • [17]

    Karlsson P, Nyengaard JR, Polydefkis M, Jensen TS. Structural and functional assessment of skin nerve fibres in small-fibre pathology. Eur J Pain 2015;19:1059–70.PubMedWeb of ScienceCrossrefGoogle Scholar

  • [18]

    Karlsson P, Porretta-Serapiglia C, Lombardi R, Jensen TS, Lauria G. Dermal innervation in healthy subjects and small fiber neuropathy patients: a stereological reappraisal. J Peripher Nerv Syst 2013;18:48–53.CrossrefPubMedWeb of ScienceGoogle Scholar

  • [19]

    Uceyler N, Eberle T, Rolke R, Birklein F, Sommer C. Differential expression patterns of cytokines in complex regional pain syndrome. Pain 2007;132:195–205.CrossrefPubMedWeb of ScienceGoogle Scholar

  • [20]

    Uceyler N, Rogausch JP, Toyka KV, Sommer C. Differential expression of cytokines in painful and painless neuropathies. Neurology 2007;69:42–9.CrossrefWeb of SciencePubMedGoogle Scholar

About the article

Received: 2019-03-11

Revised: 2019-03-20

Accepted: 2019-03-28

Published Online: 2019-04-29

Published in Print: 2019-07-26


Authors’ statements

Research funding: The study was funded by the Independent Research Fund Denmark (ID: DFF-4183-00311) and supported by the Department of Anaesthesiology and Intensive Care, Aarhus University Hospital, Aarhus, Denmark. P. Karlsson is funded by the International Diabetic Neuropathy Consortium (IDNC), which is supported by a Novo Nordisk Foundation Challenge Programme grant (NNF14OC0011633) and a research grant by the Novo Nordisk Foundation (NNF18OC0052301).

Conflict of interest: L. Nikolajsen has previously received honoraria for serving on Grünenthal advisory boards and speakers’ panels. P. Karlsson receives honoraria for consultancy for Grünenthal, unrelated to this work. N. Buch has no conflict of interest to declare.

Informed consent: Informed consent has been obtained from all individuals included in this study.

Ethical approval: The study got ethical approval from the Regional Research Ethics Committee of Central Denmark and the Danish Data Protection Agency.

Author’s contributions: All authors contributed to planning of the study, interpretation of results, and writing of the manuscript. Nina Buch examined the patients and took the skin biopsies, and Páll Karlsson stained and analysed the skin biopsies.


Citation Information: Scandinavian Journal of Pain, Volume 19, Issue 3, Pages 623–627, ISSN (Online) 1877-8879, ISSN (Print) 1877-8860, DOI: https://doi.org/10.1515/sjpain-2019-0042.

Export Citation

©2019 Scandinavian Association for the Study of Pain. Published by Walter de Gruyter GmbH, Berlin/Boston. All rights reserved..Get Permission

Comments (0)

Please log in or register to comment.
Log in